Kennebec Savings Bank’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.47K Hold
121
0.01% 242
2026
Q1
$6.15K Hold
121
0.01% 210
2025
Q4
$3.57K Hold
121
﹤0.01% 231
2025
Q3
$3.13K Buy
121
+95
+365% +$2.65K ﹤0.01% 244
2025
Q2
$717 Hold
26
﹤0.01% 249
2025
Q1
$737 Hold
26
﹤0.01% 267
2024
Q4
$914 Hold
26
﹤0.01% 243
2024
Q3
$1.74K Buy
+26
New +$2.39K ﹤0.01% 260

Other funds holding MRNA

Kennebec Savings Bank's MRNA Position: Q2 2026 in Review

Kennebec Savings Bank held its Moderna (MRNA) position steady in Q2 2026 at 121 shares worth $8.47K. The position accounts for 0.01% of the portfolio, ranked #242.

Kennebec Savings Bank first reported a position in MRNA in Q3 2024 and has held it in 8 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Kennebec Savings Bank held 121 shares of Moderna worth $8.47K as of Q2 2026.
  • Kennebec Savings Bank left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.01% of Kennebec Savings Bank's portfolio in Q2 2026, its #242 holding.
  • Kennebec Savings Bank first reported a position in Moderna in Q3 2024 and has held it in 8 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Kennebec Savings Bank's 13F filing for Q2 2026, filed 13 Jul 2026.